Home › NDC Lookup › RxCUI directory › RxCUI 967388

Amphotericin B liposomal 50 MG Injection [AmBisome] — RxCUI 967388

RxNorm drug concept · Semantic branded drug
RxCUI 967388 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI967388
Official nameAmphotericin B liposomal 50 MG Injection [AmBisome]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAmBisome 50 MG Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)460 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amphotericin B Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amphotericin B injection is reserved for serious, potentially life-threatening fungal infections that need powerful treatment fast. It's given directly into your vein so it gets in...
  • Why am I getting this medication instead of something I take by mouth?
  • It's actually pretty common to feel chills, have a fever, feel nauseous, or notice your blood pressure change during or after the infusion — especially early in treatment. The good...
  • Kidney stress is a real and important concern with amphotericin B. Your care team will check your kidney function regularly with blood tests throughout your treatment. The liposoma...
📖 Read our full Amphotericin B Injection guide →

🕸️ Concept Web — How Amphotericin B liposomal 50 MG Injection [AmBiso... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amphotericin B liposomal 50 MG Injection [AmBisome] RxCUI 967388

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Amphotericin B 732
    • Amphotericin B liposomal 236594
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • AmBisome 151338
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amphotericin B Injection 1737431
    • Amphotericin B liposomal Injection 2645777
    • Amphotericin B Injectable Product 1152913
    • Amphotericin B liposomal Injectable Product 2663632
    • Amphotericin B Injection [AmBisome] 2285809
    • Amphotericin B liposomal Injection [AmBisome] 2658188
    • AmBisome Injectable Product 1170661
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amphotericin B liposomal 50 MG Injection SCD · 967385
  • Amphotericin B liposomal 50 MG SCDC · 1737433
  • Amphotericin B Injection SCDF · 1737431
  • Amphotericin B liposomal Injection SCDFP · 2645777
  • Amphotericin B Injectable Product SCDG · 1152913
  • Amphotericin B liposomal Injectable Product SCDGP · 2663632

Brand-Name Concepts

  • Amphotericin B liposomal 50 MG [AmBisome] SBDC · 1737436
  • Amphotericin B Injection [AmBisome] SBDF · 2285809
  • Amphotericin B liposomal Injection [AmBisome] SBDFP · 2658188
  • AmBisome Injectable Product SBDG · 1170661
  • AmBisome BN · 151338

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 967388 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00469-3051-30 12.5 mL in 1 VIAL, SINGLE-DOSE (0469-3051-30) AmBisome Astellas Pharma US, Inc. 1997-08-11
Observed labelers: Astellas Pharma US, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0289 Amphotericin b liposome inj 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.